Skip to main content

MODELOS DE INTERACCION MICROBIOTA-HOSPEDADOR EN EL ENTORNO INTESTINAL Y SU APLICACION EN EL DESARROLLO DE PRODUCTOS PROBIOTICOS Y PREBIOTICOS

AGL2013-43770-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates

  • Nogacka, Alicja
  • Salazar, Nuria
  • Arboleya, Silvia
  • Alaez, Lidia
  • Hernández-Barranco, Ana María
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
[Background]: Disturbances in the early establishment of the intestinal microbiota may produce important implications for the infant’s health and for the risk of disease later on. Different perinatal conditions may be affecting the development of the gut microbiota. Some of them, such as delivery mode or feeding habits, have been extensively assessed whereas others remain to be studied, being critical to identify their impact on the microbiota and, if any, to minimize it. Antibiotics are among the drugs most frequently used in early life, the use of intrapartum antimicrobial prophylaxis (IAP), present in over 30% of deliveries, being the most frequent source of exposure. However, our knowledge on the effects of IAP on the microbiota establishment is still limited. The aim of the present work was to evaluate the impact of IAP investigating a cohort of 40 full-term vaginally delivered infants born after an uncomplicated pregnancy, 18 of which were born from mothers receiving IAP., [Results]: Fecal samples were collected at 2, 10, 30, and 90 days of age. We analyzed the composition of the fecal microbiota during the first 3 months of life by 16S rRNA gene sequencing and quantified fecal short chain fatty acids by gas chromatography. The presence of genes for resistance to antibiotics was determined by PCR in the samples from 1-month-old infants. Our results showed an altered pattern of intestinal microbiota establishment in IAP infants during the first weeks of life, with lower relative proportions of Actinobacteria and Bacteroidetes and increased of Preoteobacteria and Firmicutes. A delay in the increase on the levels of acetate was observed in IAP infants. The analyses of specific antibiotic resistance genes showed a higher occurrence of some β-lactamase coding genes in infants whose mothers received IAP., [Conclusions]: Our results indicate an effect of IAP on the establishing early microbiota during the first months of life, which represent a key moment for the development of the microbiota-induced host homeostasis. Understanding the impact of IAP in the gut microbiota development is essential for developing treatments to minimize it, favoring a proper gut microbiota development in IAP-exposed neonates., This work was founded by the EU Joint Programming Initiative—A Healthy Diet for a Healthy Life (JPI HDHL, http://www.healthydietforhealthylife.eu/) as well as the Spanish Ministry of Economy and Competitiveness (MINECO) (Project “EarlyMicroHealth” PCIN-2015-233 and Project AGL2013-43770R), and Italian Ministry of Education, University and Research (MIUR) grant to MV and CM. A. Nogacka was the recipient of a FPI contract from MINECO, and NS benefits from a postdoctoral “Juan de la Cierva-Incorporación” grant from MINECO. The Grant GRUPIN14–043 from “Plan Regional de Investigación del Principado de Asturias” is also acknowledged., We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations

  • Valdés-Varela, Lorena
  • Ruas-Madiedo, Patricia
  • Gueimonde Fernández, Miguel
The use of selected probiotics, prebiotics and/or synbiotics, constitute an interesting dietary strategy for intestinal microbiota modulation in case of dysbiosis. Species of the genus Bifidobacterium are among the most currently used probiotics for human consumption since they have shown beneficial effects in the prevention and treatment of some disorders. Bifidobacteria are saccharolytic microorganisms, but their ability to use different carbohydrates varies among strains. In this study, we investigate the utilization of three prebiotic substrates (two different short-chain fructo-oligosaccharides [scFOS] and inulin) by strains of Bifidobacterium, in order to determine the synbiotic potential of the different probiotic/prebiotic combinations. Batch culture fermentations from six Bifidobacterium strains (Bifidobacterium longum IPLA20021, B. longum IPLA20022, Bifidobacterium animalis IPLA20031, B. animalis IPLA20032, B. animalis IPLA20020 and B. animalis Bb12) were carried out in the presence of inulin or scFOS (Synergy or Actilight), or glucose, as carbon source. Bifidobacteria levels were quantified by plate counting. The pH and production of organic acids in the different batch-culture fermentations were also determined. Our results showed that all the studied strains of B. animalis and B. longum were able to utilize scFOS but not inulin. The use of scFOS as carbon source affected the pattern of metabolite's production, when compared with cultures carried out in glucose, particularly in the case of B. longum. The results indicated that the scFOS are well suited to be used in combination with B. animalis or B. longum strains for the development of synbiotic foods or food supplements., The partial funding through the project AGL2013-43770R from Plan Nacional de I + D (Ministry of Science and Innovation) and Project GRUPIN14-043 from Plan de Ciencia, Tecnología e Innovación 2013–2017 (Feder Funds and Principado de Asturias) are also acknowledged. L. Valdés was the recipient of a JAE-Pre fellowship granted by CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Nutrition and the gut microbiome in the elderly

  • Salazar, Nuria
  • Valdés-Varela, Lorena
  • González Solares, Sonia
  • Gueimonde Fernández, Miguel
  • González de los Reyes-Gavilán, Clara
The gut microbiota is the assembly of microorganisms living in our intestine and their genomes are known as the microbiome. The correct composition and functionality of this microbiome is essential for maintaining a “healthy status.” Aging is related to changes in the gut microbiota which are frequently associated with physiological modifications of the gastrointestinal tract, as well as, to changes in dietary patterns, together with a concomitant decline in cognitive and immune function, all together contributing to frailty. Therefore, nutritional strategies directed at restoring the microbiota in the elderly have to be addressed from a global perspective, considering not only the microbiota but also other extra-intestinal targets of action. The present review aims at summarizing the current knowledge on intestinal microbiota alterations and other functions impaired in the elderly and to analyze tools for implementing nutritional strategies, through the use of probiotics, prebiotics or specific nutrients in order to counterbalance such alterations., Authors receive financial support from Plan Estatal de I+D (Spanish Ministry of Economy and Competitiveness) through the project AGL2013-43770-R, and from “Plan Regional de Investigación” of Principado de Asturias through the Grant GRUPIN14-043. Both projects receive cofounding from European Union FEDER funds. N. Salazar benefits from a post-doctoral “Clarín” contract (Marie Curie European Co-Fund Program) linked to the grant ACB14-08 co-funded by the Marie Curie European CoFund Program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Selection of potential probiotic bifidobacteria and prebiotics for elderly by using in vitro faecal batch cultures

  • Valdés-Varela, Lorena
  • Salazar, Nuria
  • González Solares, Sonia
  • Arboleya, Silvia
  • Rios-Covián, David
  • Genovés, Salvador
  • Ramón, Daniel
  • González de los Reyes-Gavilán, Clara
  • Ruas-Madiedo, Patricia
  • Gueimonde Fernández, Miguel
The gut microbiota plays an important role in host health. The ageing process affects this microbial community, and therefore, the use of functional foods to restore the microbiota of elderly constitutes an interesting strategy. To this end, probiotics and prebiotics targeted at correcting the specific microbiota alterations occurring during senescence are needed. We performed an in vitro selection of bifidobacterial strains and prebiotic substrates on the basis of their ability to counterbalance the specific microbiota aberrancies previously identified in the elderly population. Batch cultures of faeces from elderly were carried out adding different strains of Bifidobacterium or prebiotics. The effects of these strains/prebiotics upon gut microbiota were assessed by quantitative PCR and the concentrations of short chain fatty acids determined by gas chromatography-FID/MS. The target-specific selection process applied in this study allowed the preliminary selection of two Bifidobacterium strains and a prebiotic fructooligosaccharide on the basis of their specific properties for the modulation of the microbiota of elders. Overall, this study identifies potentially probiotic strains and prebiotic substrates for the development of functional foods specifically targeted to the senior population., The partial funding through the projects AGL2010-16525 and AGL2013-43770R from Plan Nacional de I+D and Project GRUPIN14-043 from Plan de Ciencia, Tecnología e Innovación 2013–2017 (European Union Feder Funds and Principado de Asturias) is also acknowledged. L. Valdés was the recipient of a JAE-Pre fellowship granted by CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Real-time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups

  • Nogacka, Alicja
  • Ruas-Madiedo, Patricia
  • Gómez López, Esther
  • Solís, Gonzalo
  • Fernández, Nuria
  • Suárez, Marta
  • Suárez, Ana
  • Salazar, Nuria
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
Several in vitro screening tests have been used for selecting probiotic strains; however they often show low predictive value and only a limited number of strains have demonstrated functionality in vivo. The most used in vitro tests represent a very simplified version of the gut environment, especially since they do not consider the accompanying microbiota. Therefore, there is a need to develop sensitive and discriminating in vitro models including the microbiota. Here we developed an in vitro model to discriminate among microbiotas/fecal waters from different population groups. To this end samples were obtained from seven healthy adults, five IBD-patients, ten full-term and ten preterm newborns. Fecal microbiotas were purified and their impact, as well as that of the fecal waters, on HT29 cells was continuously monitored for 22 h using a real-time cell analyzer (RTCA). The composition of the purified microbiotas was assessed by 16S rRNA gene profiling and qPCR and the levels of short chain fatty acids (SCFA) determined by gas chromatography. The microbiota fractions and SCFA concentrations obtained from IBD-patients, full-term and preterm babies, showed clear differences with regard to those of the control group (healthy adults). Moreover, the purified intestinal microbiotas and fecal waters also differed from the control group in the response induced on the HT29 cells assay developed. In short, we have developed a real-time, impedance-based in vitro model for assessing the functional response induced by purified microbiotas and fecal waters upon intestinal epithelial cells. The capability of the assay for discriminating the functional responses induced, by microbiotas or fecal waters from different human groups, promises to be of help on the search for compounds/strains to restore the functionality of the microbiota-host's interaction., This work was financed by projects AGL2013-43770-R and AGL2015-64901-R from Plan Estatal de I + D + I (Spanish Ministry of Economy and Competitiveness, MINECO) and by Grant GRUPIN14-043 from Plan Regional de Investigación del Principado de Asturias, Spain. Both national and regional grants received cofounding from the European Union FEDER funds. AMN is the recipient of a predoctoral contract and NS benefits from a Juan de la Cierva postdoctoral contract, both granted by MINECO, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intestinal immunomodulation and shifts on the gut microbiota of BALB/c mice promoted by two bifidobacterium and Lactobacillus strains isolated from human samples

  • Nogacka, Alicja
  • Oddi, Sofia
  • Salazar, Nuria
  • Reinheimer, Jorge A.
  • Gueimonde Fernández, Miguel
  • Vinderola, Gabriel
  • González de los Reyes-Gavilán, Clara
Bifidobacterium animalis subsp. lactis IPLA 20020 and Lactobacillus gasseri IPLA 20212, two strains isolated from human samples, were evaluated for safety and influence over the intestinal microbiota and cytokine production by the intestinal tissue of adult BALB/c mice. Mice were divided into four groups receiving during 8 days PBS or a suspension of each strain, prepared fresh or lyophilized (bifidobacteria), at an amount of 4x108 viable cells/day. This dose could be comparable to the probiotic intake of a human adult who consumed about 100-200 mL of functional fermented milk per day, considering the usual level of probiotics in commercial products. No microbial translocation to liver or alterations in food intake, weight, and behavior were observed in treated mice. Intestinal content of secretory immunoglobulin A (s-IgA) was not affected, discarding any adverse effect on the mucosa-associated immunity. The profile of intestinal proinflammatory/regulatory cytokines after intervention evidenced that the microbial strain administered and its cellular state (fresh or lyophilized) as well as the host tissue analyzed (small or large intestine) influenced the immune response and suggests a moderate shift towards a T helper 1 profile (Th1) in the large intestine after the administration of both strains. Changes on relative levels of some intestinal microbial groups were evidenced after intervention. It is noteworthy that butyrate was positively associated with a balanced pro-Th1 immune response. Therefore, B. animalis subsp. lactis IPLA20020 and L. gasseri IPLA 20212 could be considered potential probiotic candidates to be included in functional foods for balancing the intestinal immune response., The present work was financed by the following projects: AGL2013-43770-R and PCIN-2015-233 (Project EarlyMicroHealth from the EU Joint Program Initiative HDHL), funded by the Spanish Plan Estatal de I+D+I (Ministry of Economy and Competitiveness; MINECO), Project PICT-2016-0256 supported by the Argentinian Scientific and Technological Research Funds (FonCyT), and grant GRUPIN14-043 funded by Plan Regional de Investigación del Principado de Asturias, Spain. Alicja M. Nogacka benefits from a predoctoral contract granted by MINECO. Nuria Salazar was the recipient of a Juan de la Cierva postdoctoral contract granted by MINECO and she is currently the recipient of a postdoctoral contract awarded by the Fundación para la Investigación Biosanitaria de Asturias (FINBA). The critical reading of the manuscript and useful comments of Dr. Sonia González (Department of Functional Biology, University of Oviedo, Spain) are acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Análisis en tiempo real de la influencia de microbiotas y aguas fecales de diferentes grupos humanos sobre la línea intestinal HT29

  • Nogacka, Alicja
  • Gómez López, Esther
  • Solís, Gonzalo
  • Suárez, Marta
  • Fernández, Nuria
  • Suárez, Adolfo
  • Faedo, Ceferino
  • González de los Reyes-Gavilán, Clara
  • Ruas-Madiedo, Patricia
  • Salazar, Nuria
  • Gueimonde Fernández, Miguel
Trabajo presentado en la X Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Madrid el 23 y 24 de Junio de 2016, La microbiota intestinal constituye un ecosistema complejo y dinámico que cambia a lo largo de la vida. Hasta la fecha la mayoría de los trabajos con modelos in vitro se han centrado en el análisis de la interacción entre el hospedador y cepas bacterianas aisladas. Por lo tanto, se requiere el desarrollo de modelos de estudio sencillos y económicamente asequibles, que tengan en cuenta la complejidad y funcionalidad de la microbiota intestinal en su conjunto. Dichos modelos permitirían determinar las potenciales diferencias funcionales existentes entre microbiotas de distintos grupos de población e identificar las intervenciones más adecuadas para su modulación. El trabajo que aquí se presenta evalúa la capacidad de un modelo in vitro, basado en la línea celular intestinal HT29, para detectar en tiempo real diferencias en la funcionalidad de sobrenadantes fecales (SF) y microbiotas aisladas (MA) de distintos grupos de población. Se estudiaron diferentes poblaciones humanas; adultos (n=22) subdivididos en obesos (n=9), individuos sanos normopeso (n=9) y enfermos con colitis ulcerosa (n=5). Se incluyó así mismo un grupo de neonatos (n=20), compuesto por niños a término (2-4 días de edad, n=10) y niños prematuros de la misma edad (n=10). Se caracterizó la composición microbiana de las MA mediante secuenciación masiva del gen del ARNr 16S. Así mismo, se determinaron los niveles de los ácidos grasos de cadena corta (AGCC) mediante cromatografía de gases en los SF ensayados. Por último, se monitorizó el efecto en tiempo real, empleando la tecnología RT-Cell Analyzer (RTCA), de las MA y SF sobre la proliferación y la integridad epitelial de la línea celular intestinal HT29. El modelo de interacción microbiota-hospedador desarrollado ha permitido detectar diferencias en la funcionalidad de la microbiota de distintos grupos poblacionales. Los SF de los niños producen una reducción del Cell Index (CI, medida arbitraria del equipo RTCA cuya bajada indica daño o cambio en número, morfología y/o adhesión celular), tanto en la fase de proliferación como en confluencia, comparados con los de adultos. Por el contrario, en fase de confluencia sus MA incrementan la integridad de la monocapa en comparación con las de adultos. De modo similar se han observado diferencias en la funcionalidad entre algunos de los subgrupos de adultos (obesos vs. normopeso). Hemos observado, además, correlaciones de grupos microbianos y AGCC específicos con el valor del CI. El modelo desarrollado muestra potencial para la caracterización de la funcionalidad de microbiotas complejas y del efecto resultante de la modulación de las mismas por probiótiocs, prebióticos u otros componentes funcionales de la dieta., Proyecto AGL2013-43770-R y Contrato JPI asociado (A.N.) del Plan Nacional I+D+i (MINECO), Proyecto GRUPIN14-043 del Plan Regional de Investigación (Principado de Asturias), y al Programa Clarin Marie Curie Cofund, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Microbiota intestinal, dieta y otros factores relacionados con la obesidad en humanos

  • Salazar, Nuria
  • Fernández-Navarro, Tania
  • Gutiérrez-Díaz, Isabel
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
  • González Solares, Sonia
Trabajo presentado en la 11ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Gijón (Asturias, España) del 28 al 30 de Junio de 2017, [Introducción] La obesidad es un grave problema de salud pública que conlleva un incremento en la incidencia de múltiples patologías relacionadas con el estrés oxidativo y la inflamación. Recientemente, la microbiota intestinal ha emergido como un factor clave en la regulación del metabolismo energético y se conoce que su funcionalidad está alterada en los individuos obesos, siendo más eficiente en la extracción de energía a partir de los componentes no digeribles de los alimentos. [Objetivos] Analizar las interrelaciones entre la obesidad, la dieta, el estrés oxidativo, la inflamación y la microbiota intestinal con el fin de establecer posibles dianas de intervención. [Materiales y Métodos] Se evaluó la ingesta dietética de 68 voluntarios a través de un cuestionario de frecuencias de consumo de alimentos. El análisis de la composición de la microbiota intestinal se realizó por qPCR y la actividad metabólica se determinó cuantificando los niveles de ácidos grasos de cadena corta (AGCC) mediante cromatografía de gases acoplada a detector de llama y de espectrometría de masas. Las concentraciones de leptina, malondialdehído (MDA) y proteína C reactiva se midieron a través de protocolos estandarizados. [Resultados] Los sujetos obesos presentaban mayor concentración de MDA, proteína C reactiva, leptina, y glucosa en sangre, así como mayor porcentaje de grasa corporal. Además, se observaron mayores niveles de Lactobacillus en la microbiota fecal de los individuos obesos en comparación con los individuos normopeso. Posteriormente se llevó a cabo un análisis de clusters que generó 2 grupos. El cluster II estaba definido por presencia de obesidad y un mayor estado inflamatorio y pro-oxidante simultáneamente, los niveles del grupo Bacteroides se relacionaron inversamente con el riesgo de pertenecer a este cluster y estos individuos presentaban una mayor ingesta de aceites y grasas, azúcares y salsas y una menor ingesta de frutas, frutos secos y pescado. [Conclusiones] La detección de diferencias en algunas poblaciones bacterianas en las heces de los voluntarios obesos y su relación con un determinado patrón dietético podría ser útil para el diseño de nuevas estrategias de intervención nutricional dirigidas a la prevención de la obesidad a través de la modulación de la microbiota intestinal., Proyecto GRUPIN14-043 del Plan Regional de Investigación (Principado de Asturias), Proyecto Clarín-COFUND ACB 14-08 y Proyecto Plan Nacional I+D+I AGL2013-43770R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Age-Associated Changes in Gut Microbiota and Dietary Components Related with the Immune System in Adulthood and Old Age: A Cross-Sectional Study

  • Salazar, Nuria
  • Arboleya, Silvia
  • Fernández-Navarro, Tania
  • González de los Reyes-Gavilán, Clara
  • González Solares, Sonia
  • Gueimonde Fernández, Miguel
The fecal microbiota plays an important role in human health, and alterations in the microbiota–host interaction seem to be involved in the ageing process. Therefore, it is of interest to develop strategies for promoting a balanced microbiota in old age in order to prevent the physiological and immune decline associated with age. However, the specific microbiota changes in the transition from adulthood to senescence are not yet well understood. Here we assessed the levels of some intestinal microorganisms and short chain fatty acids (SCFAs) across different age-groups. In total, 153 adults from four age groups (<50, 50–65, 66–80, and >80 years-old) were recruited; the levels of different bacterial groups in fecal samples were determined by quantitative polymerase chain reaction (qPCR), and those of SCFA by gas chromatography. Dietary information was collected by using a Food Frequency Questionnaire. The presence of the Bifidobacterium, Faecalibacterium, Bacteroides group, and Clostridium cluster XIVa decreased with age up to 66–80 years of age, with differences reaching statistical significance for the latter group. Interestingly, the levels of some of these microorganisms recovered in the very old age group (>80 years), with these older individuals presenting significantly higher counts of Akkermansia and Lactobacillus group than adults and the younger elderly. In addition, ageing was associated with a progressively and statistically significant reduction in the fecal concentrations of SCFAs. Dietary intakes also showed some statistically significant differences among the groups for some macro- and micronutrients. Moreover, associations of some microorganisms with age and macronutrients were also evidenced. Considering the role that fecal microbiota alterations may have in terms of impairing homeostasis and resilience, our results underline the importance of understanding the ageing and immunosenescence processes by including the microbiota perspective., This research was funded by the Plan Nacional de I+D of the Ministry of Economy and Competitiveness (projects AGL2013-43770-R and AGL2017-83653R) and from the Alimerka Foundation (Spain). NS is the recipient of a postdoctoral contract awarded by the Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA), whereas SA is the recipient of a Marie Curie contract funded by the EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In vitro evaluation of different prebiotics on the modulation of Gut Microbiota composition and function in Morbid Obese and normal-weight subjects

  • Nogacka, Alicja
  • Salazar, Nuria
  • Arboleya, Silvia
  • Ruas-Madiedo, Patricia
  • Mancabelli, Leonardo
  • Suárez, Adolfo
  • Martinez-Faedo, Ceferino
  • Ventura, Marco
  • Tochio, Takumi
  • Hirano, Katsuaki
  • Endo, Akihito
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
The gut microbiota remains relatively stable during adulthood; however, certain intrinsic and environmental factors can lead to microbiota dysbiosis. Its restoration towards a healthy condition using best-suited prebiotics requires previous development of in vitro models for evaluating their functionality. Herein, we carried out fecal cultures with microbiota from healthy normal-weight and morbid obese adults. Cultures were supplemented with different inulin-type fructans (1-kestose, Actilight, P95, Synergy1 and Inulin) and a galactooligosaccharide. Their impact on the gut microbiota was assessed by monitoring gas production and evaluating changes in the microbiota composition (qPCR and 16S rRNA gene profiling) and metabolic activity (gas chromatography). Additionally, the effect on the bifidobacterial species was assessed (ITS-sequencing). Moreover, the functionality of the microbiota before and after prebiotic-modulation was determined in an in vitro model of interaction with an intestinal cell line. In general, 1-kestose was the compound showing the largest effects. The modulation with prebiotics led to significant increases in the Bacteroides group and Faecalibacterium in obese subjects, whereas in normal-weight individuals, substantial rises in Bifidobacterium and Faecalibacterium were appreciated. Notably, the results obtained showed differences in the responses among the tested compounds but also among the studied human populations, indicating the need for developing population-specific products., The present work was financed by the project AGL2013-43770-R (receiving funds from the Ministry of Economy and Competitiveness—MINECO and the European Union FEDER funds) and by a contract with the company β- Food Sciences (Chita, Japan). Alicja M Nogacka was the recipient of a predoctoral contract granted by MINECO (reference BES-2014-068796), and S.A. received a postdoctoral Juan de la Cierva contract (Ministry of Science, Innovation and Universities, Spain, Ref. IJCI-2017-32156). Nuria Salazar is the recipient of a postdoctoral contract awarded by the Biosanitary Research Foundation in Asturias (FINBA, Spain), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In vitro Selection of Probiotics for Microbiota Modulation in Normal-Weight and Severely Obese Individuals: Focus on Gas Production and Interaction With Intestinal Epithelial Cells

  • Nogacka, Alicja
  • González de los Reyes-Gavilán, Clara
  • Arboleya, Silvia
  • Ruas-Madiedo, Patricia
  • Martinez-Faedo, Ceferino
  • Suárez, Adolfo
  • He, Fang
  • Harata, Gaku
  • Endo, Akihito
  • Salazar, Nuria
  • Gueimonde Fernández, Miguel
The intestinal microbiota plays important roles in the maintenance of health. Strategies aiming at its modulation, such as probiotics, have received a deal of attention. Several strains have been studied in different in vitro models; however, the correlation of results obtained with the in vivo data has been limited. This questions the usefulness of such in vitro selection models, traditionally relying on over-simplified tests, not considering the influence of the accompanying microbiota or focusing on microbiota composition without considering functional traits. Here we assess the potential of six Bifidobacterium, Lactobacillus and Lacticaseibacillus strains in an in vitro model to determine their impact on the microbiota not just in terms of composition but also of functionality. Moreover, we compared the responses obtained in two different population groups: normal-weight and severely obese subjects. Fecal cultures were conducted to evaluate the impact of the strains on specific intestinal microbial groups, on the production of short-chain fatty acids, and on two functional responses: the production of gas and the interaction with human intestinal epithelial cells. The response to the different probiotics differed between both human groups. The addition of the probiotic strains did not induce major changes on the microbiota composition, with significant increases detected almost exclusively for the species added. Higher levels of gas production were observed in cultures from normal-weight subjects than in the obese population, with some strains being able to significantly reduce gas production in the latter group. Moreover, in obese subjects all the Bifidobacterium strains tested and Lacticaseibacillus rhamnosus GG were able to modify the response of the intestinal cells, restoring values similar to those obtained with the microbiotas of normal-weight subjects. Our results underline the need for the screening and selection of probiotics in a target-population specific manner by using appropriate in vitro models before enrolling in clinical intervention trials., The present work was mainly financed by the project AGL2013-43770-R (receiving funds from the Ministry of Economy and Competitiveness—MINECO and the European Union FEDER funds), and partly by projects AGL2017-83653-R (AEI/FEDER, UE), and RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE) and by a contract with the company Takanashi Milk Products (Yokohama, Japan). AN was the recipient of a predoctoral contract granted by MINECO (reference BES-2014-068796). SA is currently financed by a postdoctoral Juan de la Cierva contract (Ministry of Science, Innovation and Universities, Spain, ref. IJCI-2017-32156) and NS is currently the recipient of a postdoctoral contract awarded by the Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Impacto de la obesidad severa y la pérdida de peso sobre la microbiota y el metaboloma fecal

  • Nogacka, Alicja
  • González de los Reyes-Gavilán, Clara
  • Martinez-Faedo, Ceferino
  • Ruas-Madiedo, Patricia
  • Suárez, Adolfo
  • Mancabelli, Leonardo
  • Ventura, Marco
  • Cifuentes, Alejandro
  • León, Carlos
  • Gueimonde Fernández, Miguel
  • Salazar, Nuria
Trabajo presentado al XXVIII Congreso Nacional de Microbiología, celebrado en formato virtual, durante los días 28 de junio a 2 de julio de 2021., Agradecimientos: Proyectos AGL2013-43770-R, AGL2017-83653-R y RTI2018-098288- B-I00, contratos BES-2014-068796 y IJCI-2015-19885., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Impact of extreme obesity and diet-induced weight loss on the fecal metabolome and gut microbiota

  • Nogacka, Alicja
  • González de los Reyes-Gavilán, Clara
  • Martinez-Faedo, Ceferino
  • Ruas-Madiedo, Patricia
  • Suárez, Adolfo
  • Mancabelli, Leonardo
  • Ventura, Marco
  • Cifuentes, Alejandro
  • León, Carlos
  • Gueimonde Fernández, Miguel
  • Salazar, Nuria
[Scope]: A limited number of human studies have characterized fecal microbiota and metabolome in extreme obesity and after diet-induced weight loss., [Methods and results]: Fecal samples from normal-weight and extremely obese adults and from obese participants before and after moderate diet-induced weight loss are evaluated for their interaction with the intestinal adenocarcinoma cell line HT29 using an impedance-based in vitro model, which reveals variations in the interaction between the gut microbiota and host linked to obesity status. Microbiota composition, short chain fatty acids, and other intestinal metabolites are further analyzed to assess the interplay among diet, gut microbiota, and host in extreme obesity. Microbiota profiles are distinct between normal-weight and obese participants and are accompanied by fecal signatures in the metabolism of biliary compounds and catecholamines. Moderate diet-induced weight loss promotes shifts in the gut microbiota, and the primary fecal metabolomics features are associated with diet and the gut–liver and gut–brain axes., [Conclusions]: Analyses of the fecal microbiota and metabolome enable assessment of the impact of diet on gut microbiota composition and activity, supporting the potential use of certain fecal metabolites or members of the gut microbiota as biomarkers for the efficacy of weight loss in extreme obesity., The present work was mainly financed by the project AGL2013-43770-R (receiving funds from the Ministry of Economy and Competitiveness—MINECO and the European Union FEDER funds), and partly by projects AGL2017-83653-R (AEI/FEDER, UE), and RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE). A.M.N. was the recipient of a predoctoral contract granted by MINECO (reference BES-2014-068796) and N.S. received a postdoctoral Juan de la Cierva Contract (Ministry of Science, Innovation and Universities, Spain, reference IJCI-2015-19885) and currently she has a postdoctoral contract awarded by the Biosanitary Research Foundation in Asturias (FINBA, Spain)., Peer reviewed